Fosrenol Tablet, Chewable
Product Images NDC 54092-252

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 11 technical images submitted to the FDA as part of the official labeling for Fosrenol (NDC 54092-252). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Takeda Pharmaceuticals America, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1 (Fosrenol 01)

FDA Label Image

Principal Display Panel (500 mg Tablet Bottle Label)

Principal Display Panel (500 mg Tablet Bottle Label)
FOSRENOL is a medication manufactured by Takeda Pharmaceuticals America, Inc. in Italy. It comes in chewable tablet form with active ingredients of 500mg of lanthanum as lanthanum carbonate hydrate. The medication guide enclosed must be given to each patient by the pharmacist. Tablets should not be swallowed whole and must be chewed or crushed completely before swallowing. It should be taken with or immediately after meals. The package insert contains complete prescribing information. The proper storage requirement is at 25°C (77°F), and excursions are permitted between 15-30°C (59-86'F).*
FDA Label Image

Principal Display Panel (500 mg Tablet Bottle Package)

Principal Display Panel (500 mg Tablet Bottle Package)
NDC 54092-252-90 is a prescription medicine containing lanthanum carbonate hydrate used to reduce high levels of phosphate in the blood for patients with chronic kidney disease. It comes in chewable tablet form and must not be swallowed whole. Patients should chew it completely before swallowing or take it with food. The active ingredients are colloidal silicon dioxide, dextrates, and magnesium stearate. For more information, patients should visit the website. It should be kept between 15-30°C (59-86°F) and distributed by Takeda Pharmaceuticals America, Inc., in two bottles with 45 chewable tablets each. The package insert contains full prescribing information. Pharmacists must ensure that packages are not broken.*
FDA Label Image

Principal Display Panel (750 mg Tablet Bottle Label)

Principal Display Panel (750 mg Tablet Bottle Label)
This is a medication named FOSRENOL, which consists of 750mg of lanthanum. The medication comes in the form of chewable tablets that should not be swallowed whole, and should be taken with or after meals. The inactive ingredients in the medication are colloidal silicon dioxide, dextrates, and magnesium stearate. The medication guide should be enclosed in the package, and the full prescribing information is available in the package insert. The tablets should be stored between 15-30°C (59-86°F).*
FDA Label Image

Principal Display Panel (750 mg Tablet Bottle Package)

Principal Display Panel (750 mg Tablet Bottle Package)
FOSRENOL (lanthanum carbonate) is a medication that comes in chewable tablets with 750 mg of active ingredient per tablet. It is used to control high levels of phosphorus in patients with end-stage kidney disease. The tablets should not be swallowed whole, but chewed or crushed before swallowing, and taken with or immediately after meals. This medication should be stored at temperatures between 15-30°C (59-86°F). Each package contains 6 bottles, and each bottle contains 15 chewable tablets, designed for one month of therapy. For full prescribing information, please refer to the package insert.*
FDA Label Image

Principal Display Panel (1000 mg Tablet Bottle Label)

Principal Display Panel (1000 mg Tablet Bottle Label)
This is the description of a prescription medication called FOSRENOL. It contains 1000mg of lanthanum as lanthanum carbonate hydrate and is available in chewable tablets. The product must not be swallowed whole, but chewed or crushed before swallowing. The inactive ingredients include colloidal silicon dioxide, dextrates, and starch. The medication must be taken with or immediately after meals. The package insert contains full prescribing information, and each patient is required to receive the enclosed Medication Guide. It is recommended to store the product at room temperature between 15-30°C (59-86F).*
FDA Label Image

Principal Display Panel (1000 mg Tablet Bottle Package)

Principal Display Panel (1000 mg Tablet Bottle Package)
FOSRENOL is a medication that comes in chewable tablets. Each tablet contains 1000 mg of lanthanum carbonate hydrous, alongside colloidal silicon dioxide, Gextratos, and magnesium stearate. The medication should not be swallowed whole and needs to be chewed or crushed completely before swallowing, and it is recommended to take it with or immediately after meals. The packaging insert provides full prescribing information about FOSRENOL. It is also noted that each patient package contains nine bottles, with ten chewable tablets each, designed as one month's therapy. This medication is distributed by Takeda Pharmaceuticals America, Inc., located in Lexington, MA, USA. For more information, you can visit www.fosrenol.com.*
FDA Label Image

Principal Display Panel (750 mg Packet Carton)

Principal Display Panel (750 mg Packet Carton)
Fosrenol is an oral powder medication indicated for the treatment of hyperphosphatemia in patients with end-stage renal disease. The active ingredient is lanthanum carbonate, which should be mixed with a small quantity of soft food. Fosrenol comes as stick packs with each providing 750mg of lanthanum carbonate. This medication is available only with a doctor's prescription. For complete information on this medication, refer to the package insert.*
FDA Label Image

Principal Display Panel (750 mg Packet Carton)

Principal Display Panel (750 mg Packet Carton)
Fosrenol is an oral powder medication containing Lanthanum carbonate. The recommended dose is 750 mg, which should be mixed with a small quantity of soft food and taken immediately. The medication is available in sachets containing 10 stick packs, and there are 9 cartons in total. It is manufactured in Germany and distributed in the USA. The text includes a package insert and prescription information.*
FDA Label Image

Principal Display Panel (1000 mg Packet Carton)

Principal Display Panel (1000 mg Packet Carton)
This is a medication description for Fosrenol oral powder. It is a lanthanum carbonate medication, available in 1000 mg stick packs. It must be mixed with a small quantity of food before consumption and kept at room temperature. The active ingredient is 1000 mg of lanthanum carbonate, which is present in each sick pack. The inactive ingredients include coloring agents and lubricants. The medication is available only on prescription. The manufacturer of the medication is Takace, and the medication is manufactured and distributed in Germany.*
FDA Label Image

Principal Display Panel (1000 mg Packet Carton)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.